
Sign up to save your podcasts
Or


"Many New mRNA Applications." This story, by Robert Langreth for Bloomberg Businessweek, explains how Moderna plans to use its mRNA technology to develop shots for influenza, HIV, Zika—and maybe even cancer.
See omnystudio.com/listener for privacy information.
By Bloomberg3.7
376376 ratings
"Many New mRNA Applications." This story, by Robert Langreth for Bloomberg Businessweek, explains how Moderna plans to use its mRNA technology to develop shots for influenza, HIV, Zika—and maybe even cancer.
See omnystudio.com/listener for privacy information.

1,731 Listeners

979 Listeners

406 Listeners

1,188 Listeners

2,194 Listeners

969 Listeners

685 Listeners

193 Listeners

1,043 Listeners

1,311 Listeners

64 Listeners

30 Listeners

62 Listeners

4 Listeners

58 Listeners

233 Listeners

229 Listeners

63 Listeners

85 Listeners

78 Listeners

84 Listeners

81 Listeners

408 Listeners

10 Listeners

22 Listeners

12 Listeners

7 Listeners

2 Listeners

114 Listeners

24 Listeners